<DOC>
	<DOCNO>NCT00005105</DOCNO>
	<brief_summary>OBJECTIVES : I . Determine mutation gene encode insulin-like growth factor-I receptor lead relative insulin-like growth factor-I insensitivity produce intrauterine growth retardation child .</brief_summary>
	<brief_title>Genetic Study Insulin-Like Growth Factor-I Receptor Mutations Patients With Intrauterine Growth Retardation</brief_title>
	<detailed_description>PROTOCOL OUTLINE : Patients undergo blood draw . Insulin-like growth factor-I ( IGF-I ) insulin-like growth factor bind protein-3 ( IGFBP-3 ) measure . Patients whose IGF-I IGFBP-3 level average test presence mutation insulin-like growth factor-I receptor .</detailed_description>
	<mesh_term>Fetal Growth Retardation</mesh_term>
	<criteria>Intrauterine growth retardation ( IUGR ) , define birth weight le 2 standard deviation mean Usher McLean Deficient `` catchup '' growth ( stature le 5th percentile growth chart age 18 month ) Normal elevate circulate concentration insulinlike growth factorI ( IGFI ) insulinlike growth factor bind protein3 ( IGFBP3 ) IGFI IGFBP3 within 95th percentile confidence interval age No clinical explanation poor prenatal postnatal growth No IUGR due maternal toxemia , endocrine disease , gastrointestinal disease , significant heart disease , chromosomal abnormality No condition know retard growth</criteria>
	<gender>All</gender>
	<minimum_age>18 Months</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>December 2003</verification_date>
	<keyword>endocrine disorder</keyword>
	<keyword>intrauterine growth retardation</keyword>
	<keyword>rare disease</keyword>
</DOC>